Comprehensive immune profiling of melanoma-draining lymph nodes identifies plasmacytoid dendritic cells as new biomarker for PD-L1 blockade
Emma Reynaud, Sonya Belherazem, Özge Cicek Sener, Sarah Hofmann, Alperen Acari, Pragati Lodha, Shruthi Hemanna, Nicolò Coianiz, Volker Ast, Sònia Tugues, Lothar C. Dieterich
The paper identifies plasmacytoid dendritic cells (pDCs) in tumor-draining lymph nodes as a potential biomarker for predicting response to PD-L1 blockade therapy in melanoma.
bioRxiv · Aug 22, 2025 · PreprintImmunology